Y-mAbs Therapeutics (YMAB) PT Lowered to $67 at Wedbush, Following Earnings

February 26, 2021 3:34 PM EST Send to a Friend

Wedbush analyst David Nierengarten lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Y-mAbs Therapeutics (YMAB) PT Lowered to $67 at Wedbush, Following Earnings

Member Login

Free News Feed